blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0910382

EP0910382 - SQUALAMINE IN COMBINATION WITH OTHER ANTI-CANCER AGENTS FOR TREATING TUMORS [Right-click to bookmark this link]
Former [1999/17]TREATMENT OF CARCINOMAS USING SQUALAMINE IN COMBINATION WITH OTHER ANTI-CANCER AGENTS
[2002/49]
StatusNo opposition filed within time limit
Status updated on  16.04.2004
Database last updated on 15.07.2024
Most recent event   Tooltip16.04.2004No opposition filed within time limitpublished on 02.06.2004  [2004/23]
Applicant(s)For all designated states
GENAERA CORPORATION
5110 Campus Drive
Plymouth Meeting, PA 19462 / US
[N/P]
Former [2003/44]For all designated states
GENAERA CORPORATION
5110 Campus Drive
Plymouth Meeting PA 19462 / US
Former [2003/24]For all designated states
MAGAININ PHARMACEUTICALS INC.
5110 Campus Drive
Plymouth Meeting PA 19462 / US
Former [1999/17]For all designated states
MAGAININ PHARMACEUTICALS INC.
5110 Campus Drive
Plymouth Meeting PA 19462 / US
Inventor(s)01 / ZASLOFF, Michael
274 Linden Lane
Merion Station, PA 19066 / US
02 / WILLIAMS, Jon
11 Darvel Drive
Robbinsville, NJ 08691 / US
[1999/17]
Representative(s)Goulard, Sophie, et al
Cabinet ORES 36 Rue de St Pétersbourg
75008 Paris Cedex / FR
[N/P]
Former [2003/23]Goulard, Sophie, et al
Cabinet ORES, 36,rue de St Pétersbourg
75008 Paris Cedex / FR
Former [1999/17]Mouget-Goniot, Claire
Cabinet Orès, 6, Avenue de Messine
75008 Paris / FR
Application number, filing date97921396.425.04.1997
[1999/17]
WO1997US07011
Priority number, dateUS19960016387P26.04.1996         Original published format: US 16387 P
[1999/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9740835
Date:06.11.1997
Language:EN
[1997/47]
Type: A1 Application with search report 
No.:EP0910382
Date:28.04.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 06.11.1997 takes the place of the publication of the European patent application.
[1999/17]
Type: B1 Patent specification 
No.:EP0910382
Date:11.06.2003
Language:EN
[2003/24]
Search report(s)International search report - published on:EP06.11.1997
ClassificationIPC:A61K31/56, A61K45/00, A61P35/00, // (A61K45/00, 31:56)
[2002/49]
CPC:
A61K31/575 (EP,US); A61K33/243 (EP,US); A61P35/00 (EP)
C-Set:
A61K31/575, A61K2300/00 (US,EP);
A61K31/575, A61K31/00 (US,EP);
A61K33/24, A61K2300/00 (EP,US);
A61K33/24, A61K31/575 (US,EP)
Former IPC [1999/17]A61K31/56
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/17]
TitleGerman:SQUALAMIN IN KOMBINATION MIT ANDEREN ANTIKREBS-MITTELEN ZUR BEHANDLUNG VON TUMOREN[2002/49]
English:SQUALAMINE IN COMBINATION WITH OTHER ANTI-CANCER AGENTS FOR TREATING TUMORS[2002/49]
French:LA SQUALAMINE EN ASSOCIATION AVEC D'AUTRES AGENTS ANTICANCEREUX POUR LE TRAITEMENT DES TUMEURS[2002/49]
Former [1999/17]BEHANDLUNG VON KARZINOMEN MIT SQUALAMINE KOMBINIERT MIT ANDEREN ANTIKREBS-MITTELEN
Former [1999/17]TREATMENT OF CARCINOMAS USING SQUALAMINE IN COMBINATION WITH OTHER ANTI-CANCER AGENTS
Former [1999/17]TRAITEMENT DES CARCINOMES PAR LA SQUALAMINE EN ASSOCIATION AVEC D'AUTRES AGENTS ANTICANCEREUX
Entry into regional phase22.10.1998National basic fee paid 
22.10.1998Designation fee(s) paid 
22.10.1998Examination fee paid 
Examination procedure23.10.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
25.11.1998Amendment by applicant (claims and/or description)
25.11.1998Examination requested  [1999/17]
23.05.2002Despatch of a communication from the examining division (Time limit: M04)
05.09.2002Reply to a communication from the examining division
31.10.2002Communication of intention to grant the patent
06.02.2003Fee for grant paid
06.02.2003Fee for publishing/printing paid
Opposition(s)12.03.2004No opposition filed within time limit [2004/23]
Fees paidRenewal fee
28.04.1999Renewal fee patent year 03
03.04.2000Renewal fee patent year 04
02.04.2001Renewal fee patent year 05
12.04.2002Renewal fee patent year 06
14.04.2003Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]JPS6133121  ;
 [PYD]WO9640151  (MAGAININ PHARMA [US]) [PYD] 1-29* page 7, paragraph 3 - page 8, paragraph 1; claim 1 *;
 [Y]  - KONOVALOVA ET AL., "Increasing the therapeutic efficacy of antitumor drugs", CHEMICAL ABSTRACTS, (19890717), vol. 111, no. 3, Database accession no. 17264, XP002037635 [Y] 1-29 * abstract *
    [ ] - IZV.AKAD.NAUK SSSR,SER.BIOL., (1989), vol. 3, pages 466 - 468
 [Y]  - DATABASE WPI, 1, Derwent World Patents Index, vol. 86, no. 13, Database accession no. 86-085704, XP002037636 & JPS6133121 A 19860217 (NISSEI MARINE KOGYO) [Y] 1-29 * abstract *
 [Y]  - Biosis Previews Biosis no. 82085007, XP002037634 [Y] 1-29 * abstract *
    [ ] - T.IKEKAWA ET AL., "Studies on antitumor activity of squalene and its related compounds", YAKUGAKU ZASSHI, (1986), vol. 7, pages 578 - 582
 [Y]  - JANE HOLMES, "Shark cartilage for cancer treatment?", P AND T, (199603), vol. 21, no. 3, pages 159 - 160, XP000602614 [Y] 1-29 * the whole document *
 [Y]  - "Aminosterol antibiotic", CURR.OPIN.THER.PAT., (1993), vol. 3, no. 9, pages 1369 - 1370, XP002037633 [Y] 1-29 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.